Flagship Pioneering (United States)
- Research works
- 23 ▲ 6657% vs 2013–17
- Citations
- 861 37.1 per fractional work
- Top-10% rate
- 46.6% record average 16.5%
- Open access
- 76% world 28%
Not ranked overall: Flagship Pioneering (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.0×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 7.0×
- Immunology and Microbiology 5.0×
- Chemistry 2.9×
- Medicine 1.9×
- Materials Science 1.4×
- Decision Sciences 1.1×
- Neuroscience 0.7×
- Physics and Astronomy 0.6×
- Nursing 0.5×
- Agricultural and Biological Sciences 0.3×
- Engineering 0.3×
- Environmental Science 0.2×
- Economics, Econometrics and Finance 0.1×
- Social Sciences 0.1×
Which keywords describe research at Flagship Pioneering (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Machine Learning, Gene Expression, Molecular Dynamics, Monoclonal Antibodies, Innovation, Cancer, Inflammation and Epidemiology.
- Innovation
- Epidemiology
- Molecular Dynamics
- Gene Expression
- Machine Learning
- Inflammation
- Cancer
- Monoclonal Antibodies
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 8 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 8 words, with their numbers
- Machine Learning2▲ 4.5×6 topics
- Gene Expression1▲ 8.7×7 topics
- Inflammation1▲ 2.2×11 topics
- Molecular Dynamics1▲ 20×2 topics
- Cancer1▲ 3.5×12 topics
- Epidemiology1▲ 1.20×13 topics
- Monoclonal Antibodies1▲ 33×3 topics
- Innovation1▲ 4.8×2 topics
Which research topics does Flagship Pioneering (United States) publish most on?
By volume in 2022–2025: CRISPR and Genetic Engineering, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and Single-cell and spatial transcriptomics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CRISPR and Genetic Engineering Molecular Biology 1 works
- 2 CAR-T cell therapy research Oncology 1 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 4 Single-cell and spatial transcriptomics Molecular Biology 0 works
- 5 Biomedical Ethics and Regulation Physiology 0 works
- 6 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 0 works
- 7 Inflammatory mediators and NSAID effects Pharmacology 0 works
- 8 Protein purification and stability Molecular Biology 0 works
- 9 Cell Image Analysis Techniques Biophysics 0 works
- 10 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Flagship Pioneering (United States)'s research output changed?
Output in 2018–2022 was 6657% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.